These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2858269)

  • 1. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
    Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
    Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Substitution of fluphenazine decanoate with oxyprothepine decanoate in long-term maintenance therapy in schizophrenia].
    David I; Filip V; Hellerová P
    Cesk Psychiatr; 1986 Oct; 82(5):313-7. PubMed ID: 2878734
    [No Abstract]   [Full Text] [Related]  

  • 5. Further clinical experience with oxyprothepin-decanoate.
    Kalvach Z; Hálková E; Bastecký J
    Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
    Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
    [No Abstract]   [Full Text] [Related]  

  • 7. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
    Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
    Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK; Wong KE; Tay WK; Gill RC
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical comparison of oxyprothepin and clotepine in schizophrenic patients (controlled study).
    Náhunek K; Svestka J; Cesková E; Rysánek R
    Act Nerv Super (Praha); 1979 Oct; 21(3):133-5. PubMed ID: 42259
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isofloxythepine in an open study.
    Papezová H; David I; Alda M; Soucek R
    Act Nerv Super (Praha); 1989 Jun; 31(2):121-2. PubMed ID: 2572133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
    Ushakov IuV; Kravchenko NE; Kopeĭko GI; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):99-104. PubMed ID: 1979463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effectiveness of isofloxythepin--an open study].
    Zapletálek M; Tůma I; Kudrnová K
    Cesk Psychiatr; 1985 Aug; 81(4):242-6. PubMed ID: 2864141
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of maintenance therapy with oxyprothepin decanoate in schizophrenics: open study.
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Act Nerv Super (Praha); 1979 Oct; 21(3):138-9. PubMed ID: 42261
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical predictors of schizophrenic patient response to neuroleptics.
    Korínková V
    Act Nerv Super (Praha); 1989 Jun; 31(2):115-6. PubMed ID: 2572131
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.
    Jain RC; Ananth JV; Lehmann HE; Ban TA
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):585-9. PubMed ID: 241609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.